Chew Bryan J W, Khajuria Ankur, Ibanez Javier
Department of Plastic and Reconstructive Surgery, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Plast Reconstr Surg Glob Open. 2019 Nov 27;7(11):e2541. doi: 10.1097/GOX.0000000000002541. eCollection 2019 Nov.
Guidelines recommend temporal artery biopsy (TAB) for patients suspected of having giant cell arteritis (GCA). We evaluated the impact of TAB on the diagnosis and management of patients with suspected GCA at a tertiary plastic surgery unit.
A retrospective review of all TAB procedures performed at our centre over 7 years was performed. One hundred and one patients were included in the study. Patients were classified into 3 diagnostic groups: confirmed (positive TAB), presumed (negative TAB with high clinical suspicion) and unlikely (negative TAB with low clinical suspicion). The clinical presentation and management for each group were compared.
The average American College of Rheumatology (ACR) score was 3.07. The number of patients with an ACR score of ≥3 before TAB was 72 (71.3%) and remained the same after TAB. The number of patients who remained on steroid therapy was lower in the group with an unlikely diagnosis of GCA compared to the group with a confirmed diagnosis (p<0.05). Conversely, there was no significant difference in steroid therapy between those with a presumed and confirmed diagnosis (p>0.05).
This study found a significant difference in steroid treatment between those with confirmed GCA and those where the diagnosis was unlikely showing that TAB may support decisions regarding steroid therapy. However, TAB was inappropriately requested for patients whose pre-TAB ACR score was ≥3 as this score is sufficient for the diagnosis of GCA. Therefore, the use of TAB should be limited to cases of diagnostic uncertainty.
指南建议对疑似巨细胞动脉炎(GCA)的患者进行颞动脉活检(TAB)。我们评估了在一家三级整形外科单位中,TAB对疑似GCA患者诊断和管理的影响。
对我们中心7年来进行的所有TAB手术进行回顾性研究。101名患者纳入研究。患者分为3个诊断组:确诊(TAB阳性)、推定(TAB阴性但临床高度怀疑)和不太可能(TAB阴性且临床怀疑度低)。比较每组的临床表现和管理情况。
美国风湿病学会(ACR)平均评分为3.07。TAB前ACR评分≥3的患者有72名(71.3%),TAB后该数字保持不变。GCA诊断不太可能的组中继续接受类固醇治疗的患者数量低于确诊组(p<0.05)。相反,推定诊断和确诊诊断的患者在类固醇治疗方面无显著差异(p>0.05)。
本研究发现确诊GCA的患者与诊断不太可能的患者在类固醇治疗上存在显著差异,表明TAB可能有助于关于类固醇治疗的决策。然而,对于TAB前ACR评分≥3的患者,TAB的要求并不恰当,因为该评分足以诊断GCA。因此,TAB的使用应限于诊断存在不确定性的病例。